Stephen Elledge's Har­vard lab again proves fruit­ful with the launch of high-through­put an­ti­body start­up

Af­ter work­ing with es­teemed Har­vard pro­fes­sor Stephen Elledge to launch TCR-fo­cused TScan Ther­a­peu­tics three years ago, the Long­wood Fund ap­proached the sci­en­tist last spring about …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER